NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • #TrumpTrade
  • 24-HOUR Pass →
  • Invest ↗
Sign in Subscribe

Morgan Stanley Upgrades Akamai, Sees Growth Ahead

Morgan Stanley upgrades Akamai to Overweight, raising its price target to $115 as growth prospects improve across cloud, security, and compute services.

Morgan Stanley Upgrades Akamai, Sees Growth Ahead
Credit: Akamai
Already have an account? Sign in.
01/12/2026 · 6:35 AM
AKAM
/ Don't stop with just one post.

Related↓

Wall Street Moves: Analysts Upgrade and Downgrade Key Tech Stocks
Featured/ 12/15/2025 · 7:43 AM

Wall Street Moves: Analysts Upgrade and Downgrade Key Tech Stocks

Morgan Stanley and KeyBanc updated their views on major tech stocks, upgrading Doximity, Asana, and Akamai, while downgrading ServiceNow and Adobe as part of their 2026 outlook.

/ Subscriber only
/ Read more

Feed↓

FDA Cracks Down on Compounded GLP-1 Weight Loss Drugs
Featured/ 02/06/2026 · 5:34 PM

FDA Cracks Down on Compounded GLP-1 Weight Loss Drugs

FDA plans to restrict non-approved compounded GLP-1 drugs sold by Hims & Hers and compounding pharmacies, citing safety concerns and misleading marketing practices.

/ Subscriber only
DraftKings Teams Up With Crypto.com for Expanded Prediction Markets
02/06/2026 · 4:05 PM

DraftKings Teams Up With Crypto.com for Expanded Prediction Markets

DraftKings (DKNG) partners with Crypto.com to expand prediction markets, adding player-specific sports contracts and new categories including politics and entertainment.

/ Subscriber only
Pfizer’s Chantix Move Seen as Positive Signal for Achieve Life Sciences
02/06/2026 · 3:53 PM

Pfizer’s Chantix Move Seen as Positive Signal for Achieve Life Sciences

Analysts say Pfizer listing Chantix on TrumpRx may support Achieve Life Sciences and boost confidence in cytisinicline’s approval prospects.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe